Life Healthcare’s subsidiary, Life Molecular Imaging, has sub-licensed its radiotherapeutic products to Lantheus Holdings for $35 million. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log...
